Danish pharmaceutical company Novo Nordisk (NVO) on Tuesday said that it has submitted an application to the European ...

The country’s manufacturing output grew at a faster rate in May due mainly to increases in the production of food and ...

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as a breakthrough against a disease that takes ...

There are several successful investing strategies in the stock market and one of them is Dogs of the Dow. It is a strategy ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Coartem Baby, which was cleared by health authorities in Switzerland, will fill an important gap in treatment. Novartis plans ...

Shares of Eton Pharmaceuticals rose sharply in premarket trading Tuesday after the pharmaceutical company said the Food and Drug Administration has accepted its application seeking approval of its ...

In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...